| Peer-Reviewed

Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital

Received: 25 July 2021    Accepted: 26 August 2021    Published: 31 August 2021
Views:       Downloads:
Abstract

INTRODUCTION: Kidney disease is becoming a worldwide public health problem with an increase in incidence and prevalence, poor outcomes and high cost. Rational prescription is necessary in kidney disease patients. These patients are at higher risk of developing drug related problems since they need complex therapeutic regimens that include comorbid conditions like diabetes mellitus, hypertension, coronary artery disease and infection that require frequent monitoring and dosage adjustment. Inappropriate use of medications can increase adverse drug effects, which can be reflected by excessive length of hospital stays, excessive health care utilization and cost. OBJECTIVES: The objective of the study was to assess, evaluate and analyze the prescribing pattern of drugs in kidney disease and their dose adjustments in medicine and emergency department of tertiary care teaching hospital. METHODOLOGY: The study was conducted for a period of 6 months. Ethical clearance was obtained from Institutional Ethical Committee of S C S College of Pharmacy, Harapanahalli. Collected data was analyzed to identify the current prescribing trend and dosage regimen in the management of renal failure patients and to know whether the prescribing rationality was obtained in Medicine and Emergency unit in hospital by using KDIGO guidelines. RESULTS: A total of 140 patients were enrolled in the study according to the inclusion criteria in which 104 were males and 36 were females. 134 CKD cases and 6 AKI cases were found. In the study, 105 (75%) patients were hypertensive, 62 (44.28%) patients were anemic, 54 (38.57%) patients were diabetic and dyslipidemia was associated with 21 (15%) patients. 87 patients were on hemodialysis. On the basis of ATC classification of drugs, cardiovascular system (35.7%) class of drugs was the commonly prescribed followed by drugs for alimentary tract and metabolism (25.97%), anti-infective (10.11%) and blood and blood forming agents (7.97%). Out of 1028 studied drugs, only 105 (10.21%) required dose adjustment where 76 (72.38%) were adjusted and 29 (27.61%) were not adjusted. CONCLUSION: This study illustrates the need for proper dose adjustment and drug utilization pattern in patients with renal failure. Appropriate dosing of antibiotics as well as other drugs, including narrow therapeutic drugs play a vital role in preventing dose related adverse reactions and toxicities. This study will provide an outline for management strategies and will influence the decision making process in clinical practice.

Published in International Journal of Biomedical Engineering and Clinical Science (Volume 7, Issue 3)
DOI 10.11648/j.ijbecs.20210703.13
Page(s) 52-64
Creative Commons

This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.

Copyright

Copyright © The Author(s), 2024. Published by Science Publishing Group

Keywords

Kidney Disease, Rational Prescription, KDIGO, Emergency Department, Medicine Department

References
[1] Tamilselvan T, Veerapandiyan A K, Karthik N. Study on drug utilization pattern of chronic renal failure patients in a tertiary care hospital. Internatinoal Journal of Pharmacy and Pharmaceutical Sciences. 2014; 6 (9): 482-484.
[2] Henok Getachew, Yewondwossen Tadesse, Workineh Shibeshi. Drug dosage adjustment in hospitalized patients with renal impairment at Tikur Anbessa specialized hospital, Addis Ababa, Ethiopia. BMC Nephrology. 2015; 16: 158.
[3] Rajiv Ahlawat, Sanjay D’cruz, Pramil Tiwari. Drug utilization pattern in chronic kidney disease patients at a tertiary care public teaching hospital: Evidence from a cross-sectional study. J Pharma Care Health. 2016; 3: 1.
[4] Marlies Karsch-Volk, Elisa Schmid. et al. Kidney function and clinical recommendations of drug dose adjustment in geriatric patients. BMC Geriatrics. 2013; 13: 92.
[5] Neeta J. Kanani, Vimesh R. Mistry, Sandeep J. Rathva. Drug utilization pattern in chronic kidney disease patients at a tertiary care teaching hospital. Innova Pharm Pharmacother. 2019; 7 (2): 31-36.
[6] Sindura P, Balaiah Sandyapakula, B Silvya Grace. et al. Assessment of drug prescribing pattern in patient of CKD along with CVD in tertiary care hospital. Int. J. Pharm. Sci. Rev. Res. 2018; 49 (2): 33-38.
[7] Sridhar Srimath Tirumala Konduru, Javvaji Naga Sai Kumar. et al. Assessment of drug use patterns and quality of life in haemodialysis patients. EJPMR. 2018; (6): 628-637.
[8] Latha Kamath, Hema N. G, Himamani S. A study of drug utilization pattern in patients of chronic kidney disease at a tertiary care hospital. IJBCP. 2019 Feb; 8 (2): 170-175.
[9] Soumya Sandra, Divya Agarwal, Sanjay Kumar, Sudhanshu Sekhar Mishra. A study on the drug utilization pattern in patients with chronic kidney disease with emphasis on antibiotics. J Integr Nephrol Androl. 2015; 2: 85-9.
[10] Paul Muntner, Amanda Anderson, Jeanne C, Zhen Chen, Virginia Ford, Gail M. et al. Hypertension awareness, treatment, and control in adults with ckd: results from the chronic renal insufficiency cohort (cric) study. Am J Kidney Dis. 2010 March; 55 (3): 441-445.
[11] P Anushman Abishek, Rajendra Panda, Rajashree Samal, Namitha M, Srikantha Mohanty. Drug utilization pattern and adverse events in patients with chronic kidney disease undergoing maintanence haemodialysis at a teritiary care hospital of odisha. Journal of Clinical and Diagnostic Research. 2017 Oct; 11 (10): 11-16.
[12] Rayane Saad, Souheli Hallit, Bahia Chahine. Evaluation of renal drug dosing adjustment in chronic kidney disease patients at two university hospitals in Lebanon. Pharmacy Practice. 2019 Jan-March; 17 (1): 1304.
[13] Abdulrahman M Alahdal, Ahmed A E. Evaluation of applying drug dose adjustment by physicians in patients with renal impairment. Saudi Pharmaceutical Journal. 2012; 20: 217-220.
[14] Aurelio C. M, Elena U Sanz, Carles I Navalon, Juan B. C Romero, Juan J Gascon Canovas. Influence of equation used to estimate the renal function in dosage potentially nephrotoxic drug. Eur J Hosp Pharm. 2015; 22: 23-27.
[15] Shivraj G, Prakash B D, Shruthi S K, Vinayak V H, Avinash A K M, Sonal N V. Markers of renal function. N Am J Med Sci. 2010 April; 2 (4): 170-173.
[16] Tom N. L. H, Jane E. C, Sophie L. S, Jacob Stevastos, Darren M. R. Clinical pharmacokinetics in kidney disease. Clin J Am Soc Nephrol. 2018 July 6; 13 (7): 1085-1095.
[17] Rowa Al- Ramahi. Medication prescribing patterns among chronic kidney disease patients in a hospital in malaysis. Saudi J Kidney Dis Transpl. 2012; 23 (2): 403-408.
[18] John W P, John M. A simple method to detect recovery of glomerular filtration rate following acute kidney injury. Biomed Research International. 2014; 55; 61-69.
[19] Beverly E, Liana D, Castel, Mathew McGinnis, Amy B, Rudolph C Cane Jr. et al. Economic and clinical outcomes resulting from the stage 4 chronic kidney disease case management quality improvement initiative. Prof Case Management. 2017; 22 (6): 291-298.
[20] Ayse L, Thomas C D, Mathew R W, Stephen L S, Robert H C, Laurence S M. Hepatology. 2014 April; 59 (4): 1532-1542.
[21] Leonie V M, Moerland, Adam F C, Jacobus B. Urinary kidney biomarkers for early detection of nephrotoxicity in clinical drug development. British Journal of Clinical Pharmacology. 2013; 10: 12-23.
[22] Gudrun B, Bengt R, Sven Erik Ricksten. Assessing glomerular filtration rate in critically ill patients with acute kidney injury- true GFR versus urinary creatinine clearance and estimating equations. Critical Care. 2013; 17: R108.
[23] Anna T M, Steven F, Yoshitsugu O, Kamyar K Z. Preservation of residual kidney function in hemodialysis patients: reviving an old concept for contemporary practice. Kidney Int. 2016 Aug; 90 (2): 262-271.
[24] Stephan G, David H, Saber B, Alexander Z, Nuttha L, Ron Wald et al. Delayed versus early initiation of renal replacement therapy for severe acute kidney injury. Lancet. 2020; 395: 1506-1515.
[25] Min Zhan, Wendy L. St. Peter et al. Patterns of NSAIDs use and their association with other analgesic use in CKD. Clin J Am Soc Nephrol. 2017 Nov 7; 12 (11): 1778-1788.
[26] Mahboob Rahman, Dawei C, Harold IF, Alan S G, Jiang H, John W K. et al. Association between chronic kidney disease progression and cardiovascular disease: Results from the CRIC study. Am J Nephrol. 2014; 40 (5): 399-407.
[27] Manjula K T, Kristi E Yaffe, Chi-Yuan Hsu, Jingrong Yang, Stephen Sozio, Michael F. et al. Cognitive impairement and progression of CKD. Amj Kidney Dis. 2016 july; 68 (1): 77-83.
[28] Mierala D, Wei Yang, Qiang Pan, Lawrence A, Keith B, Jing Chen et al. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease. J Am Heart Assoc. 2015; 4: 144-159.
[29] Elaine K U, Charles E, McCulloch, Eric V, Feng Li, Kirsten L J. Use of antihypertensive agents and association with risk of adverse outcomes in chronic kidney disease: focus on angiotensin converting enzyme inhibitors and angiotensin receptor blockers. J Am Heart Assoc. 2018; 7: 155-161.
[30] Jiang He, Michael S, Amanda A, Jason A R, Harold I F, Radhakrishna Reddy K et al. Risk factors for heart failure in patients with chronic kidney disease. J Am Heart Assoc. 2017; 6: 33-41.
[31] Tamara I, Cheryl A M Anderson, Mary B L, Dawei Xie, Orlando M G, Leigh K R. et al. Diuretics, calciuria and secondary hyperparathyroidism in the chronic renal insufficiency cohort (CRIC). Nephrol Dial Transplant (2011); 26: 1258-1265.
[32] Jay Shah, Tejas K, Saurabh B, Rima B S, Sanjay D. Study of utilization pattern of anti-hypertensive drugs in hypertensive diabetic patients with or without reduced renal function at tertiary care teaching hospital. ijmsph. 2013; 2: 167-172.
[33] Samina S Khan, Waqar H K, Rekha A, Hocine T, Brian J. G. P, Annamaria T K. Health care utilization among patients with chronic kidney disease. Kidney International. 2002; 62: 229-236.
Cite This Article
  • APA Style

    Stephin V. Mathew, Santhosh Uttangi, Dayana Noble, Manisha Ravi, Stephy K. Mathew, et al. (2021). Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital. International Journal of Biomedical Engineering and Clinical Science, 7(3), 52-64. https://doi.org/10.11648/j.ijbecs.20210703.13

    Copy | Download

    ACS Style

    Stephin V. Mathew; Santhosh Uttangi; Dayana Noble; Manisha Ravi; Stephy K. Mathew, et al. Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital. Int. J. Biomed. Eng. Clin. Sci. 2021, 7(3), 52-64. doi: 10.11648/j.ijbecs.20210703.13

    Copy | Download

    AMA Style

    Stephin V. Mathew, Santhosh Uttangi, Dayana Noble, Manisha Ravi, Stephy K. Mathew, et al. Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital. Int J Biomed Eng Clin Sci. 2021;7(3):52-64. doi: 10.11648/j.ijbecs.20210703.13

    Copy | Download

  • @article{10.11648/j.ijbecs.20210703.13,
      author = {Stephin V. Mathew and Santhosh Uttangi and Dayana Noble and Manisha Ravi and Stephy K. Mathew and J. S. Venkatesh},
      title = {Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital},
      journal = {International Journal of Biomedical Engineering and Clinical Science},
      volume = {7},
      number = {3},
      pages = {52-64},
      doi = {10.11648/j.ijbecs.20210703.13},
      url = {https://doi.org/10.11648/j.ijbecs.20210703.13},
      eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ijbecs.20210703.13},
      abstract = {INTRODUCTION: Kidney disease is becoming a worldwide public health problem with an increase in incidence and prevalence, poor outcomes and high cost. Rational prescription is necessary in kidney disease patients. These patients are at higher risk of developing drug related problems since they need complex therapeutic regimens that include comorbid conditions like diabetes mellitus, hypertension, coronary artery disease and infection that require frequent monitoring and dosage adjustment. Inappropriate use of medications can increase adverse drug effects, which can be reflected by excessive length of hospital stays, excessive health care utilization and cost. OBJECTIVES: The objective of the study was to assess, evaluate and analyze the prescribing pattern of drugs in kidney disease and their dose adjustments in medicine and emergency department of tertiary care teaching hospital. METHODOLOGY: The study was conducted for a period of 6 months. Ethical clearance was obtained from Institutional Ethical Committee of S C S College of Pharmacy, Harapanahalli. Collected data was analyzed to identify the current prescribing trend and dosage regimen in the management of renal failure patients and to know whether the prescribing rationality was obtained in Medicine and Emergency unit in hospital by using KDIGO guidelines. RESULTS: A total of 140 patients were enrolled in the study according to the inclusion criteria in which 104 were males and 36 were females. 134 CKD cases and 6 AKI cases were found. In the study, 105 (75%) patients were hypertensive, 62 (44.28%) patients were anemic, 54 (38.57%) patients were diabetic and dyslipidemia was associated with 21 (15%) patients. 87 patients were on hemodialysis. On the basis of ATC classification of drugs, cardiovascular system (35.7%) class of drugs was the commonly prescribed followed by drugs for alimentary tract and metabolism (25.97%), anti-infective (10.11%) and blood and blood forming agents (7.97%). Out of 1028 studied drugs, only 105 (10.21%) required dose adjustment where 76 (72.38%) were adjusted and 29 (27.61%) were not adjusted. CONCLUSION: This study illustrates the need for proper dose adjustment and drug utilization pattern in patients with renal failure. Appropriate dosing of antibiotics as well as other drugs, including narrow therapeutic drugs play a vital role in preventing dose related adverse reactions and toxicities. This study will provide an outline for management strategies and will influence the decision making process in clinical practice.},
     year = {2021}
    }
    

    Copy | Download

  • TY  - JOUR
    T1  - Drug Utilization Evaluation Study and Dose Adjustment in Patients with Kidney Disease in Tertiary Care Hospital
    AU  - Stephin V. Mathew
    AU  - Santhosh Uttangi
    AU  - Dayana Noble
    AU  - Manisha Ravi
    AU  - Stephy K. Mathew
    AU  - J. S. Venkatesh
    Y1  - 2021/08/31
    PY  - 2021
    N1  - https://doi.org/10.11648/j.ijbecs.20210703.13
    DO  - 10.11648/j.ijbecs.20210703.13
    T2  - International Journal of Biomedical Engineering and Clinical Science
    JF  - International Journal of Biomedical Engineering and Clinical Science
    JO  - International Journal of Biomedical Engineering and Clinical Science
    SP  - 52
    EP  - 64
    PB  - Science Publishing Group
    SN  - 2472-1301
    UR  - https://doi.org/10.11648/j.ijbecs.20210703.13
    AB  - INTRODUCTION: Kidney disease is becoming a worldwide public health problem with an increase in incidence and prevalence, poor outcomes and high cost. Rational prescription is necessary in kidney disease patients. These patients are at higher risk of developing drug related problems since they need complex therapeutic regimens that include comorbid conditions like diabetes mellitus, hypertension, coronary artery disease and infection that require frequent monitoring and dosage adjustment. Inappropriate use of medications can increase adverse drug effects, which can be reflected by excessive length of hospital stays, excessive health care utilization and cost. OBJECTIVES: The objective of the study was to assess, evaluate and analyze the prescribing pattern of drugs in kidney disease and their dose adjustments in medicine and emergency department of tertiary care teaching hospital. METHODOLOGY: The study was conducted for a period of 6 months. Ethical clearance was obtained from Institutional Ethical Committee of S C S College of Pharmacy, Harapanahalli. Collected data was analyzed to identify the current prescribing trend and dosage regimen in the management of renal failure patients and to know whether the prescribing rationality was obtained in Medicine and Emergency unit in hospital by using KDIGO guidelines. RESULTS: A total of 140 patients were enrolled in the study according to the inclusion criteria in which 104 were males and 36 were females. 134 CKD cases and 6 AKI cases were found. In the study, 105 (75%) patients were hypertensive, 62 (44.28%) patients were anemic, 54 (38.57%) patients were diabetic and dyslipidemia was associated with 21 (15%) patients. 87 patients were on hemodialysis. On the basis of ATC classification of drugs, cardiovascular system (35.7%) class of drugs was the commonly prescribed followed by drugs for alimentary tract and metabolism (25.97%), anti-infective (10.11%) and blood and blood forming agents (7.97%). Out of 1028 studied drugs, only 105 (10.21%) required dose adjustment where 76 (72.38%) were adjusted and 29 (27.61%) were not adjusted. CONCLUSION: This study illustrates the need for proper dose adjustment and drug utilization pattern in patients with renal failure. Appropriate dosing of antibiotics as well as other drugs, including narrow therapeutic drugs play a vital role in preventing dose related adverse reactions and toxicities. This study will provide an outline for management strategies and will influence the decision making process in clinical practice.
    VL  - 7
    IS  - 3
    ER  - 

    Copy | Download

Author Information
  • Department of Pharmacy Practice, SCS College of Phamacy, Harapanahalli, Karnataka, India

  • Department of Pharmacy Practice, SCS College of Phamacy, Harapanahalli, Karnataka, India

  • Department of Pharmacy Practice, SCS College of Phamacy, Harapanahalli, Karnataka, India

  • Department of Pharmacy Practice, SCS College of Phamacy, Harapanahalli, Karnataka, India

  • Department of Pharmacy Practice, SCS College of Phamacy, Harapanahalli, Karnataka, India

  • Department of Pharmacy Practice, SCS College of Phamacy, Harapanahalli, Karnataka, India

  • Sections